Our data indicated that remission of NAFLD reduced the risk of incident diabetes, which might be explained by: 1) the improvement of hepatic insulin resistance; 2) alteration of hepatokine production, such as a reduction of fetuin A levels (33). This evidence concerns the gene AHSG and diabetes mellitus.